John Porter

1.4k citations

38 papers · 1.1k · h-index 19

Impact in

Reproductive Medicine top 5%
- Hypothalamic control of reproductive hormones
- Ovarian function and disorders
Immunology and Allergy top 10%
- Cell Adhesion Molecules Research

Papers in

Molecular Biology 22
- Chemical Synthesis and Analysis 7
- Receptor Mechanisms and Signaling 4
- RNA Interference and Gene Delivery 4
Immunology and Allergy 8
- Cell Adhesion Molecules Research 8

Co-authors: Jean Rivier (7 shared papers)Wylie Vale (4 shared papers)Anne Corrigan (4 shared papers)Marilyn H. Perrin (3 shared papers)Catherine Rivier (4 shared papers)James P. O’Connell (6 shared papers)John Dykert (1 shared paper)Ian Whitcombe (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (13 papers)Journal of Medicinal Chemistry (4 papers)Nature Communications (3 papers)Expert Opinion on Therapeutic Patents (2 papers)Journal of Pharmaceutical Sciences (1 paper)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

John Porter

38 papers receiving 1.1k citations

Peers

Countries citing papers authored by John Porter

Since Specialization

Citations

This map shows the geographic impact of John Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Porter more than expected).

Fields of papers citing papers by John Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Porter. The network helps show where John Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside John Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Porter Line = papers co-authored together John Porter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro Journal of Medicinal Chemistry ·Jean Rivier, John Porter, Catherine Rivier, Marilyn H. Perrin, Anne Corrigan, W. Alexander Van Hook, Reuben P. Siraganian, Wylie Vale	1986	120
2	Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors Bioorganic & Medicinal Chemistry Letters ·John Porter, Andrew Payne, Ben de Candole, Daniel Ford, Brian Hutchinson, Graham Trevitt, James M. A. Turner, Chloe Edwards, Clare Watkins, Ian Whitcombe, Jeremy Davis, Colin Stubberfield	2008	86
3	Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer Nature Communications ·James P. O’Connell, John Porter, Boris Kroeplien, Tim Norman, Stephen Rapecki, Rachel E. Davis, David McMillan, T.L. Arakaki, Alex B. Burgin, David Fox, Tom Ceska, Fabien Lecomte, Alison Maloney, Alex Vugler, Bruce Carrington, Benjamin P. Cossins, Tim Bourne, Alastair D. G. Lawson	2019	81
4	Small molecule c-Met kinase inhibitors: a review of recent patents Expert Opinion on Therapeutic Patents ·John Porter	2010	68
5	Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF Nature Communications ·David McMillan, C. Martinez-Fleites, John Porter, David Fox, Rachel E. Davis, Prashant Mori, Tom Ceska, Bruce Carrington, Alastair D. G. Lawson, Tim Bourne, James P. O’Connell	2021	63
6	Automated Protein–Ligand Interaction Screening by Mass Spectrometry Journal of Medicinal Chemistry ·Hannah J. Maple, Rachel A. Garlish, Laura Rigau-Roca, John Porter, Ian Whitcombe, Christine E. Prosser, Jeffrey C. Kennedy, Alistair J. Henry, Richard J. Taylor, Matthew P. Crump, John Crosby	2011	62
7	Synthesis, resolution and characterization of ring substituted phenylalanines and tryptophans International journal of peptide & protein research ·John Porter, John Dykert, Jean Rivier	1987	52
8	Gonadotropin-Releasing Hormone Antagonists: Novel Members of the Azaline B Family Journal of Medicinal Chemistry ·Jean Rivier, Guangcheng Jiang, John Porter, Carl Hoeger, A. Grey Craig, Anne Corrigan, Wylie Vale, Catherine Rivier	1995	52
9	Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor Clinical & Experimental Metastasis ·Zili An, Xiaoen Wang, N. Willmott, Surinder K. Chander, Simon Tickle, Andrew Docherty, Andrew Mountain, Andrew T. Millican, Richard Morphy, John Porter, R. Ola Epemolu, Tetsuro Kubota, A. R. Moossa, Robert M. Hoffman	1997	48
10	Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase Bioorganic & Medicinal Chemistry Letters ·John Porter, Simon Lumb, Fabien Lecomte, James Reuberson, Anne Foley, Mark Calmiano, Kelly Le Riche, Helen Edwards, Jean Delgado, Richard J. Franklin, Jose M. Gascon-Simorte, Alison Maloney, Christoph Meier, Mark Batchelor	2008	45
11	The Gonadotropin-Releasing Hormone Pituitary Receptor Interacts with a Guanosine Triphosphate Binding Protein: Differential Effects of Guanyl Nucleotides on Agonist and Antagonist Binding* Endocrinology ·Marilyn H. Perrin, YAIRA HAAS, John Porter, Jean Rivier, Wylie Vale	1989	38
12	Discovery of 4-azaindoles as novel inhibitors of c-Met kinase Bioorganic & Medicinal Chemistry Letters ·John Porter, Simon Lumb, Richard J. Franklin, Jose M. Gascon-Simorte, Mark Calmiano, Kelly Le Riche, Bénédicte Lallemand, Jean Keyaerts, Helen Edwards, Alison Maloney, Jean Delgado, Lloyd King, Anne Foley, Fabien Lecomte, James Reuberson, Christoph Meier, Mark Batchelor	2009	33
13	Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives Bioorganic & Medicinal Chemistry Letters ·John Porter, Nigel R. A. Beeley, Byron A. Boyce, Barbara Mason, Andrew T. Millican, Kenneth Millar, J. C. Leonard, J. Richard Morphy, James P. O’Connell	1994	33
14	Potent and selective inhibitors of gelatinase-A 2. carboxylic and phosphonic acid derivatives Bioorganic & Medicinal Chemistry Letters ·J. Richard Morphy, Nigel R. A. Beeley, Byron A. Boyce, J. C. Leonard, Barbara Mason, Andrew T. Millican, Kenneth Millar, James P. O’Connell, John Porter	1994	31
15	DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma Bioconjugate Chemistry ·Sarah Hale, Richard D. Perrins, Cristina Espinosa Garcı́a, Alessandro Pace, U Aguilera Peral, Ketan Patel, Angela Byun Robinson, Philip M. Williams, Yao Ding, Gabriele Saito, Miguel Rodríguez, Ibon Perera, África G. Barrientos, Kelly Conlon, Steve Damment, John Porter, Tom Coulter	2018	29
16	Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation Bioorganic & Medicinal Chemistry Letters ·John Porter, Andrew Payne, Ian Whitcombe, Ben de Candole, Daniel Ford, Rachel A. Garlish, Adam Hold, Brian Hutchinson, Graham Trevitt, James M. A. Turner, Chloe Edwards, Clare Watkins, Jeremy Davis, Colin Stubberfield	2009	28
17	Squaric acid derivatives as VLA-4 integrin antagonists Bioorganic & Medicinal Chemistry Letters ·John Porter, Sarah C. Archibald, Kirstie Childs, David R. Critchley, John C. Head, Janeen M. Linsley, Ted A.H. Parton, Martyn K. Robinson, Anthony Shock, Richard J. Taylor, Graham J. Warrellow, Rikki Alexander, Barry Langham	2002	27
18	Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists Bioorganic & Medicinal Chemistry Letters ·John Porter, Sarah C. Archibald, Julien A. Brown, Kirstie Childs, David R. Critchley, John C. Head, Brian Hutchinson, Ted A.H. Parton, Martyn K. Robinson, Anthony Shock, Graham J. Warrellow, Albert Y. Zomaya	2002	25
19	A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF Nature Communications ·Daniel Lightwood, Rebecca Munro, John Porter, David McMillan, Bruce Carrington, Alison Turner, Anthony Scott-Tucker, Elizabeth S Hickford, Antje Schmidt, David Fox, Alison Maloney, Tom Ceska, Tim Bourne, James P. O’Connell, Alastair D. G. Lawson	2021	22
20	Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists Bioorganic & Medicinal Chemistry Letters ·Sarah C. Archibald, John C. Head, Neil Gozzard, D. Howat, Ted A.H. Parton, John Porter, Martyn K. Robinson, Anthony Shock, Graham J. Warrellow, William M. Abraham	2000	18

About John Porter

John Porter is a scholar working on Molecular Biology, Immunology and Allergy, Cancer Research, Immunology and Organic Chemistry, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (8 papers), Chemical Synthesis and Analysis (7 papers), Protease and Inhibitor Mechanisms (6 papers), Hypothalamic control of reproductive hormones (5 papers), Immune Response and Inflammation (5 papers), Receptor Mechanisms and Signaling (4 papers), RNA Interference and Gene Delivery (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Reproductive Medicine (145 citations), Immunology and Allergy (80 citations), Cancer Research (150 citations), Hepatology (71 citations) and Organic Chemistry (241 citations). John Porter has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Jean Rivier, Wylie Vale, Anne Corrigan, Marilyn H. Perrin, Catherine Rivier, James P. O’Connell, John Dykert, Ian Whitcombe, Reuben P. Siraganian and W. Alexander Van Hook. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Nature Communications, Expert Opinion on Therapeutic Patents and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John Porter

Impact in

Papers in i

In The Last Decade

John Porter

Peers

Countries citing papers authored by John Porter

Fields of papers citing papers by John Porter

All Works

About John Porter

Explore authors with similar magnitude of impact

Papers in